CD276 and neoplasm: They designed ROR1-directed CAR-T cells to co-express EpCAM or B7-H3-specific synthetic notch receptors which functioned as a logic gate to restrict CAR-T cell activity to tumor cells that expressed the ligands for the synthetic notch receptors.